Corrigendum to "The effect of esomeprazole on the upper GI tract release and systemic absorption of mesalazine from colon targeted formulations" [Int. J. Pharm. 619 (2022) 121701]
Int J Pharm
.
2024 Apr 25:655:124087.
doi: 10.1016/j.ijpharm.2024.124087.
Epub 2024 Apr 6.
Authors
Arno Van Camp
1
,
Tim Vanuytsel
2
,
Joachim Brouwers
1
,
Patrick Augustijns
3
Affiliations
1
Drug Delivery and Disposition, KU Leuven, Gasthuisberg O&N II, Herestraat 49 - box 921, 3000 Leuven, Belgium.
2
Translational Research Center for Gastrointestinal Disorders, TARGID, KU Leuven, Herestraat 49, 3000 Leuven, Belgium.
3
Drug Delivery and Disposition, KU Leuven, Gasthuisberg O&N II, Herestraat 49 - box 921, 3000 Leuven, Belgium. Electronic address: patrick.augustijns@kuleuven.be.
PMID:
38584003
DOI:
10.1016/j.ijpharm.2024.124087
No abstract available
Publication types
Published Erratum